Using aspirin for cancer prevention

PARP inhibitors in metastatic breast cancer: The present and the future

Treatment pathways for patients with triple-negative breast cancer

Immunotherapy in gastric cancers

Rectal cancer in Latin America, screening and surgery

Shaping the future of metastasis - ecancer investigates

Assessing biosimilars in the real world setting

Practical guidance on the assessment of biosimilar monoclonal antibodies: A pharmacist's perspective

Effective communication about biosimilars

The role of the pharmacist in supporting multi-disciplinary education

Comment: Immunogenicity of biosimilars

Comment: Critical quality attributes of biosimilars